After exclusion of BRCA1, BRCA2, and syndromic breast cancer genes (CDH1, PTEN, and TP53), observed pathogenic variants in ATM, BARD1, CHEK2, PALB2 and RAD51D were associated with high or moderately increased risks of breast cancer [91]. This evidence concerns the gene BARD1 and breast cancer.